Logo image of CURR

CURRENC GROUP INC (CURR) Stock Fundamental Analysis

NASDAQ:CURR - Nasdaq - KYG478621009 - Common Stock - Currency: USD

1.83  -0.04 (-2.14%)

After market: 1.79 -0.04 (-2.19%)

Fundamental Rating

1

Overall CURR gets a fundamental rating of 1 out of 10. We evaluated CURR against 0 industry peers in the Unkown industry. CURR has a bad profitability rating. Also its financial health evaluation is rather negative. CURR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CURR had positive earnings in the past year.
In the past year CURR has reported a negative cash flow from operations.
CURR Yearly Net Income VS EBIT VS OCF VS FCFCURR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 2M -2M -4M

1.2 Ratios

Industry RankSector Rank
ROA 3.95%
ROE 4.98%
ROIC N/A
ROA(3y)1.05%
ROA(5y)N/A
ROE(3y)1.22%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CURR Yearly ROA, ROE, ROICCURR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 2 -2 4

1.3 Margins

CURR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CURR Yearly Profit, Operating, Gross MarginsCURR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, CURR has less shares outstanding
The debt/assets ratio for CURR is higher compared to a year ago.
CURR Yearly Shares OutstandingCURR Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M 20M 25M
CURR Yearly Total Debt VS Total AssetsCURR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 3.96 indicates that CURR is not in any danger for bankruptcy at the moment.
CURR has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 3.96
ROIC/WACCN/A
WACCN/A
CURR Yearly LT Debt VS Equity VS FCFCURR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

CURR has a Current Ratio of 0.00. This is a bad value and indicates that CURR is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.00 indicates that CURR may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0
Quick Ratio 0
CURR Yearly Current Assets VS Current LiabilitesCURR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 1M 2M 3M 4M

More info and screens

1

3. Growth

3.1 Past

CURR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.08%, which is quite impressive.
EPS 1Y (TTM)54.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-67.1%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CURR Yearly Revenue VS EstimatesCURR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023
CURR Yearly EPS VS EstimatesCURR Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 10.76, the valuation of CURR can be described as reasonable.
CURR is valuated cheaply when we compare the Price/Earnings ratio to 29.63, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.76
Fwd PE N/A
CURR Price Earnings VS Forward Price EarningsCURR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CURR Per share dataCURR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CURR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CURRENC GROUP INC

NASDAQ:CURR (2/21/2025, 8:11:21 PM)

After market: 1.79 -0.04 (-2.19%)

1.83

-0.04 (-2.14%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)11-18 2024-11-18
Earnings (Next)03-25 2025-03-25
Inst Owners0.18%
Inst Owner ChangeN/A
Ins Owners1.51%
Ins Owner Change0%
Market Cap85.15M
AnalystsN/A
Price TargetN/A
Short Float %0.81%
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 10.76
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.93
P/tB 1.93
EV/EBITDA N/A
EPS(TTM)0.17
EY9.29%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.95
TBVpS0.95
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.95%
ROE 4.98%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)1.05%
ROA(5y)N/A
ROE(3y)1.22%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0
Quick Ratio 0
Altman-Z 3.96
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-67.1%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y47.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y27.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y27.24%
OCF growth 3YN/A
OCF growth 5YN/A